“…No adverse events were associated with the use of atropine in this study. Similarly, Peteiro et al 4 administered atropine in doses of 0.25-2.0 mg to 31 patients undergoing treadmill exercise stress echocardiography who had a very small probability of achieving submaximal heart rate. Of these patients, 77% achieved target heart We have demonstrated a significant incremental benefit of atropine in augmentation of exercise heart rate, with a subsequent reduction in the number of nondiagnostic tests based on heart rate response when compared with historical controls.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly to previously published studies, atropine was administered to patients who were unlikely or unable to achieve target heart rate. 4,[6][7][8] The supervising cardiologist, present for the full duration of the study, made a clinical assessment of the need for atropine based on patient query at each stage of exercise. This included an assessment of symptoms, heart rhythm, blood pressure, heart rate, and expectation of limiting fatigue.…”
Section: Methodsmentioning
confidence: 99%
“…While this threshold is not well validated in studies, the direct relationship between myocardial oxygen consumption and hemodynamic parameters is supportive of this heart rate goal. [3][4][5] However, these studies are significantly limited by their small sample size. Therefore, the American Society of Echocardiography recommends exercise stress rather than pharmacologic stress for patients who are capable of exercise.…”
mentioning
confidence: 99%
“…2 Several small studies have shown that atropine augmentation in treadmill exercise stress echocardiography is a safe and feasible method for increasing the percentage of patients who reach their target heart rates, increases the time acquisition window after exercise, and may improve the rate of technically adequate tests. [3][4][5] However, these studies are significantly limited by their small sample size. This study aimed to assess the utility of atropine administration to augment the chronotropic response in a large cohort of patients undergoing treadmill exercise stress echocardiography.…”
While atropine augmentation is safe and feasible, further studies are required to determine whether it is an equivalent surrogate to achieving target heart rate through exercise alone.
“…No adverse events were associated with the use of atropine in this study. Similarly, Peteiro et al 4 administered atropine in doses of 0.25-2.0 mg to 31 patients undergoing treadmill exercise stress echocardiography who had a very small probability of achieving submaximal heart rate. Of these patients, 77% achieved target heart We have demonstrated a significant incremental benefit of atropine in augmentation of exercise heart rate, with a subsequent reduction in the number of nondiagnostic tests based on heart rate response when compared with historical controls.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly to previously published studies, atropine was administered to patients who were unlikely or unable to achieve target heart rate. 4,[6][7][8] The supervising cardiologist, present for the full duration of the study, made a clinical assessment of the need for atropine based on patient query at each stage of exercise. This included an assessment of symptoms, heart rhythm, blood pressure, heart rate, and expectation of limiting fatigue.…”
Section: Methodsmentioning
confidence: 99%
“…While this threshold is not well validated in studies, the direct relationship between myocardial oxygen consumption and hemodynamic parameters is supportive of this heart rate goal. [3][4][5] However, these studies are significantly limited by their small sample size. Therefore, the American Society of Echocardiography recommends exercise stress rather than pharmacologic stress for patients who are capable of exercise.…”
mentioning
confidence: 99%
“…2 Several small studies have shown that atropine augmentation in treadmill exercise stress echocardiography is a safe and feasible method for increasing the percentage of patients who reach their target heart rates, increases the time acquisition window after exercise, and may improve the rate of technically adequate tests. [3][4][5] However, these studies are significantly limited by their small sample size. This study aimed to assess the utility of atropine administration to augment the chronotropic response in a large cohort of patients undergoing treadmill exercise stress echocardiography.…”
While atropine augmentation is safe and feasible, further studies are required to determine whether it is an equivalent surrogate to achieving target heart rate through exercise alone.
“…This percentage can be reduced by using atropine during exercise, therefore reducing the need for pharmacological stress [21] . Atropine is particularly useful for patients with reduced resting heart rate as a result of β-blocker therapy, peripheral artery disease or arthropathies.…”
Exercise echocardiography has been used for 30 years. It is now considered a consolidated technique for the diagnosis and risk stratification of patients with known or suspected coronary artery disease (CAD). Of the stress echocardiography techniques, it represents the first choice for patients who are able to exercise. Given that the cost-effectiveness and safety of stress echocardiography are higher than those of other imaging techniques, its use is likely to be expanded further. Recent research has also proposed this technique for the evaluation of cardiac pathology beyond CAD. Although the role of new technology is promising, the assessment of cardiac function relies on good quality black and white harmonic images.
Of the stress echocardiographic methods, exercise should be the first choice for patients able to exercise, according to guidelines. Among ExE modalities, treadmill ExE with acquisition of images at peak exercise has several advantages, including high sensitivity and prognostic value. Overall, sensitivity of ExE is around 80%–85%, although figures for peak imaging on the treadmill are 85%–90%. Despite it, guidelines do not mention this method.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.